Wakabayashi Y, Inoue J, Takahashi Y, Matsuki A, Kosugi-Okano H, Shinbo T, Mishima Y, Niwa O, Kominami R (2003). “Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas”. Biochem. Biophys. Res. Commun. 301 (2): 598–603. doi:10.1016/S0006-291X(02)03069-3. PMID12565905.
Bezrookove V, van Zelderen-Bhola SL, Brink A, Szuhai K, Raap AK, Barge R, Beverstock GC, Rosenberg C (2004). “A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene”. Cancer Genet. Cytogenet. 149 (1): 72–6. doi:10.1016/S0165-4608(03)00302-9. PMID15104287.
MacLeod RA, Nagel S, Drexler HG (2004). “BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia”. Cancer Genet. Cytogenet. 153 (1): 88–9. doi:10.1016/j.cancergencyto.2004.02.020. PMID15325104.
Przybylski GK, Dik WA, Wanzeck J, Grabarczyk P, Majunke S, Martin-Subero JI, Siebert R, Dölken G, Ludwig WD, Verhaaf B, van Dongen JJ, Schmidt CA, Langerak AW (2005). “Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL”. Leukemia. 19 (2): 201–8. doi:10.1038/sj.leu.2403619. PMID15668700.
Cismasiu VB, Adamo K, Gecewicz J, Duque J, Lin Q, Avram D (2005). “BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter”. Oncogene. 24 (45): 6753–64. doi:10.1038/sj.onc.1208904. PMID16091750.
Nagel S, Scherr M, Kel A, Hornischer K, Crawford GE, Kaufmann M, Meyer C, Drexler HG, MacLeod RA (2007). “Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1”. Cancer Res. 67 (4): 1461–71. doi:10.1158/0008-5472.CAN-06-2615. PMID17308084.
Kamimura K, Mishima Y, Obata M, Endo T, Aoyagi Y, Kominami R (2007). “Lack of Bcl11b tumor suppressor results in vulnerability to DNA replication stress and damages”. Oncogene. 26 (40): 5840–50. doi:10.1038/sj.onc.1210388. PMID17369851.